These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 19183238)

  • 1. Docking, virtual high throughput screening and in silico fragment-based drug design.
    Zoete V; Grosdidier A; Michielin O
    J Cell Mol Med; 2009 Feb; 13(2):238-48. PubMed ID: 19183238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Dynamics as a Tool for Virtual Ligand Screening.
    Menchon G; Maveyraud L; Czaplicki G
    Methods Mol Biol; 2018; 1762():145-178. PubMed ID: 29594772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical and practical considerations in virtual screening: a beaten field?
    Kontoyianni M; Madhav P; Suchanek E; Seibel W
    Curr Med Chem; 2008; 15(2):107-16. PubMed ID: 18220766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand docking and structure-based virtual screening in drug discovery.
    Cavasotto CN; Orry AJ
    Curr Top Med Chem; 2007; 7(10):1006-14. PubMed ID: 17508934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening in lead discovery and optimization.
    Jain AN
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):396-403. PubMed ID: 15338948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico prediction of SARS protease inhibitors by virtual high throughput screening.
    Plewczynski D; Hoffmann M; von Grotthuss M; Ginalski K; Rychewski L
    Chem Biol Drug Des; 2007 Apr; 69(4):269-79. PubMed ID: 17461975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment informatics and computational fragment-based drug design: an overview and update.
    Sheng C; Zhang W
    Med Res Rev; 2013 May; 33(3):554-98. PubMed ID: 22430881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free resources to assist structure-based virtual ligand screening experiments.
    Villoutreix BO; Renault N; Lagorce D; Sperandio O; Montes M; Miteva MA
    Curr Protein Pept Sci; 2007 Aug; 8(4):381-411. PubMed ID: 17696871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing drug discovery through in silico screening: strategies to increase true positives retrieval rates.
    Kirchmair J; Distinto S; Schuster D; Spitzer G; Langer T; Wolber G
    Curr Med Chem; 2008; 15(20):2040-53. PubMed ID: 18691055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches.
    Vucicevic J; Nikolic K; Mitchell JBO
    Curr Med Chem; 2019; 26(21):3874-3889. PubMed ID: 28707592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual Ligand Screening Using PL-PatchSurfer2, a Molecular Surface-Based Protein-Ligand Docking Method.
    Shin WH; Kihara D
    Methods Mol Biol; 2018; 1762():105-121. PubMed ID: 29594770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEKOIS: demanding evaluation kits for objective in silico screening--a versatile tool for benchmarking docking programs and scoring functions.
    Vogel SM; Bauer MR; Boeckler FM
    J Chem Inf Model; 2011 Oct; 51(10):2650-65. PubMed ID: 21774552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular descriptors and methods for ligand based virtual high throughput screening in drug discovery.
    Pozzan A
    Curr Pharm Des; 2006; 12(17):2099-110. PubMed ID: 16796558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational protein-ligand docking and virtual drug screening with the AutoDock suite.
    Forli S; Huey R; Pique ME; Sanner MF; Goodsell DS; Olson AJ
    Nat Protoc; 2016 May; 11(5):905-19. PubMed ID: 27077332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational resources for protein modelling and drug discovery applications.
    Dhaliwal B; Chen YW
    Infect Disord Drug Targets; 2009 Nov; 9(5):557-62. PubMed ID: 19594423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive assessment of flexible-ligand docking algorithms: current effectiveness and challenges.
    Huang SY
    Brief Bioinform; 2018 Sep; 19(5):982-994. PubMed ID: 28334282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practices in Molecular Docking and Structure-Based Virtual Screening.
    Dos Santos RN; Ferreira LG; Andricopulo AD
    Methods Mol Biol; 2018; 1762():31-50. PubMed ID: 29594766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.